Aza-quinoline compounds and uses thereof
US-2026076968-A1 · Mar 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Dore Michael patents
Dore Michael is listed as an inventor on 20 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dore Michael |
| Total patents | 20 |
| First publication | Oct 7, 2021 |
| Latest publication | Mar 19, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
AZA-quinoline compounds and uses thereof
US-12544374-B2 · Feb 10, 2026 · US
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
US-12479842-B2 · Nov 25, 2025 · US
Quinoline compounds and compositions for inhibiting EZH2
US-12473273-B2 · Nov 18, 2025 · US
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
US-2025270207-A1 · Aug 28, 2025 · US
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
US-12209098-B2 · Jan 28, 2025 · US
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
US-12139488-B2 · Nov 12, 2024 · US
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
US-2024317747-A1 · Sep 26, 2024 · US
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
US-12060353-B2 · Aug 13, 2024 · US
Pyrimido[5,4,d]pyrimidine compounds, compositions comprising them and uses thereof
US-2024239801-A1 · Jul 18, 2024 · US
Recent patents
Latest publications not already listed above.
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
US-2024217971-A1 · Jul 4, 2024 · US
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
US-2024140945-A1 · May 2, 2024 · US
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
US-11952386-B2 · Apr 9, 2024 · US
Quinoline compounds and compositions for inhibiting ezh2
US-2023167100-A1 · Jun 1, 2023 · US
N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2
US-2022396585-A1 · Dec 15, 2022 · US
Aza-quinoline compounds and uses thereof
US-2022280509-A1 · Sep 8, 2022 · US
Compounds and compositions for inhbiting the activity of shp2
US-2022089597-A1 · Mar 24, 2022 · US
N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2
US-2022073537-A1 · Mar 10, 2022 · US
N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2
US-2021371429-A1 · Dec 2, 2021 · US
Compounds and compositions for inhbiting the activity of shp2
US-2021309663-A1 · Oct 7, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Novartis Ag | 12 |
| Univ Montreal | 8 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 20 |
| C07D471/04 | 12 |
| C07D519/00 | 10 |
| A61K31/541 | 10 |
| A61K31/5377 | 10 |